Digitized versions of medical charts to flood the Immunoassay Interference Blockers Market at a CAGR of 6.8%
The immunoassay interference blocker-based market is expected to reach US$ 455 Mn by the end of 2031, with sales revenue expected to register 6.7% CAGR. As per Persistence Market Research’s latest revised industry analysis, the global immunoassay interference blocker market was valued at US$ 223 Mn in 2020, and is expected to exhibit a CAGR of 6.7% over the forecast...
0 Commentaires 0 Parts 2KB Vue 0 Aperçu